N-cycloalkylalkylamines, process for their preparation, their use as medicament and their synthesis intermediates

A method for treating psychoses comprising administering to a patient suffering from psychoses in an amount effective to treat said psychoses, a medicinal composition comprising in a medicinally acceptable vehicle an effective amount of an N-cycloalkylakylamine of the formula ##STR17## wherein:

• R.sub.1 is phenyl optionally mono-, di- or trisubstituted by halogen, lower alkyl, lower haloalkyl or lower alkoxy,
• R.sub.2 is lower alkyl,
• R.sub.3 is hydrogen or lower alkyl,
• R.sub.4 is cycloalkyl --CH(CH.sub.2).sub.n wherein n is an integer ranging from 2 to 5 and wherein a carbon atom of R.sub.4 optionally carries a radical R.sub.x wherein R.sub.x is lower alkyl or phenyl
• R.sub.5 is phenyl optionally mono-, di- or trisubstituted by halogen or lower alkoxy,
• Q represents an ethylene-1,2-yl group --CH.dbd.CH-- or a cyclopropane-1,2-diyl group ##STR18## and m is 1 or 2.

A method for treating a gastro-intestinal condition comprising administering to a patient suffering from a gastro-intestinal condition in an amount effective to treat said gastro-intestinal condition, a medicinal composition comprising in a medicinally acceptable vehicle an effective amount of an N-cycloalkylalkylamine of the formula ##STR19## wherein:

• R.sub.1 is phenyl optionally mono-, di- or trisubstituted by halogen, lower alkyl, lower haloalkyl or lower alkoxy,
• R.sub.2 is lower alkyl,
• R.sub.3 is hydrogen or lower alkyl,
• R.sub.4 is cycloalkyl --CH(CH.sub.2).sub.n wherein n is an integer ranging from 2 to 5 and wherein a carbon atom of R.sub.4 optionally carries a radical R.sub.x wherein R.sub.x is lower alkyl or phenyl
• R.sub.5 is phenyl optionally mono-, di- or trisubstituted by halogen or lower alkoxy,
• Q represents an ethylene-1,2-yl group --CH.dbd.CH-- or a cyclopropane-1,2-diyl group ##STR20## and m is 1 or 2.